ANGELA MURNO: Open Payments
NPI 1700990264 · TORRINGTON, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$642 in 34 payments from 12 companies in 2025. Trend: 2023 $1,194 · 2024 $833 · 2025 $642
Food & beverage: $642
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $138 |
| Madrigal Pharmaceuticals | 2 | $111 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $91 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $73 |
| Janssen Biotech, Inc. | 3 | $56 |
| Ferring Pharmaceuticals Inc. | 2 | $37 |
| Lilly USA, LLC | 2 | $36 |
| Celltrion USA Inc. | 1 | $32 |
| Intra-Sana Laboratories | 1 | $19 |
| Ardelyx, Inc. | 1 | $18 |
Products named: REZDIFFRA, XIFAXAN, TREMFYA, SKYRIZI, LINZESS, ENTYVIO, REBYOTA, OMVOH.
Industry payments across CT — which companies pay providers there.
